Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,114.00
+67.00 (6.40%)
Nov 13, 2025, 4:10 PM KST
Enzychem Lifesciences Revenue
Enzychem Lifesciences had revenue of 16.40B KRW in the quarter ending June 30, 2025, a decrease of -16.34%. This brings the company's revenue in the last twelve months to 72.71B, down -14.28% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.
Revenue (ttm)
72.71B
Revenue Growth
-14.28%
P/S Ratio
1.19
Revenue / Employee
559.33M
Employees
130
Market Cap
86.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.38B | 1.34B | 1.76% |
| Dec 31, 2023 | 76.04B | 49.40B | 185.46% |
| Dec 31, 2022 | 26.64B | 3.66B | 15.94% |
| Dec 31, 2021 | 22.98B | -2.84B | -11.01% |
| Dec 31, 2020 | 25.82B | -5.65B | -17.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |